Staphylococcus aureus-Derived α-Hemolysin Evokes Generation of Specialized Pro-resolving Mediators Promoting Inflammation Resolution
暂无分享,去创建一个
O. Werz | C. Serhan | A. Ialenti | A. Rossi | S. Pace | C. González-Estévez | B. Löffler | L. Tuchscherr | Ó. Gutiérrez-Gutiérrez | J. Gerstmeier | P. M. Jordan | Rossella Bilancia | Laura Miek | Zhigang Rao | Friedemann Börner | Vandana Arakandy | Cristina González-Estévez
[1] G. Krönke,et al. 12/15-Lipoxygenase during the regulation of inflammation, immunity, and self-tolerance , 2012, Journal of Molecular Medicine.
[2] C. Glass,et al. Phospholipase A2 regulates eicosanoid class switching during inflammasome activation , 2014, Proceedings of the National Academy of Sciences.
[3] K. Horiuchi,et al. Correction for Substrate Selectivity of Epidermal Growth Factor-Receptor Ligand Sheddases and their Regulation by Phorbol Esters and Calcium Influx , 2006, Molecular biology of the cell.
[4] O. Werz. 5-lipoxygenase: cellular biology and molecular pharmacology. , 2002, Current drug targets. Inflammation and allergy.
[5] David P. Roberson,et al. Staphylococcus aureus produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314 , 2018, Nature Communications.
[6] M. Otto. Staphylococcus aureus toxins. , 2014, Current opinion in microbiology.
[7] O. Werz,et al. 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease. , 2015, Biochimica et biophysica acta.
[8] J. Duncan,et al. ADAM10 Cell Surface Expression but Not Activity Is Critical for Staphylococcus aureus α-Hemolysin-Mediated Activation of the NLRP3 Inflammasome in Human Monocytes , 2016, Toxins.
[9] O. Werz,et al. In vivo sex differences in leukotriene biosynthesis in zymosan-induced peritonitis. , 2014, Pharmacological research.
[10] P. Saftig,et al. Leukocytes require ADAM10 but not ADAM17 for their migration and inflammatory recruitment into the alveolar space. , 2014, Blood.
[11] M. Otto,et al. The psmα Locus Regulates Production of Staphylococcus aureus Alpha-Toxin during Infection , 2014, Infection and Immunity.
[12] C. Serhan,et al. Identification and Actions of a Novel Third Maresin Conjugate in Tissue Regeneration: MCTR3 , 2016, PloS one.
[13] P. Lazarovici,et al. Staphylococcus aureus α-toxin activates phospholipases and induces a Ca2+ influx in PC12 cells , 1989 .
[14] C. Serhan,et al. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. , 2015, Seminars in immunology.
[15] P. Isakson,et al. In vivo characterization of zymosan-induced mouse peritoneal inflammation. , 1994, The Journal of pharmacology and experimental therapeutics.
[16] D. Sturdevant,et al. Role of the Accessory Gene Regulator agr in Community-Associated Methicillin-Resistant Staphylococcus aureus Pathogenesis , 2011, Infection and Immunity.
[17] H. Kuhn,et al. Structural and functional biology of arachidonic acid 15-lipoxygenase-1 (ALOX15). , 2015, Gene.
[18] O. Goldmann,et al. Staphylococcus aureus strategies to evade the host acquired immune response. , 2017, International journal of medical microbiology : IJMM.
[19] T. Foster. Immune evasion by staphylococci , 2005, Nature Reviews Microbiology.
[20] C. Wolz,et al. Exotoxins from Staphylococcus aureus activate 5-lipoxygenase and induce leukotriene biosynthesis , 2019, Cellular and Molecular Life Sciences.
[21] H. Monteil,et al. Regulation of virulence determinants in Staphylococcus aureus: complexity and applications. , 2004, FEMS microbiology reviews.
[22] Charles N Serhan,et al. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. , 2018, Journal of Clinical Investigation.
[23] Vance G. Fowler,et al. Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management , 2015, Clinical Microbiology Reviews.
[24] J. Seong,et al. Anti-inflammatory role of 15-lipoxygenase contributes to the maintenance of skin integrity in mice , 2018, Scientific Reports.
[25] C. Bachert,et al. Role of imbalance of eicosanoid pathways and staphylococcal superantigens in chronic rhinosinusitis , 2012, Allergy.
[26] C. Serhan,et al. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. , 2014, American journal of physiology. Cell physiology.
[27] S. Goerdt,et al. Macrophage activation and polarization: nomenclature and experimental guidelines. , 2014, Immunity.
[28] H. Hammad,et al. Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis , 2011, Allergy.
[29] E. Reboud,et al. Functional Consequences of Calcium Influx Promoted by Bacterial Pore-Forming Toxins , 2018, Toxins.
[30] J. B. Wardenburg,et al. Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus α-hemolysin–mediated cellular injury , 2010, Proceedings of the National Academy of Sciences.
[31] B. Mehramuz,et al. The pathogenesis of Staphylococcus aureus in autoimmune diseases. , 2017, Microbial pathogenesis.
[32] M. Fraunholz,et al. Sigma Factor SigB Is Crucial to Mediate Staphylococcus aureus Adaptation during Chronic Infections , 2015, PLoS pathogens.
[33] M. Fraunholz,et al. Post-invasion events after infection with Staphylococcus aureus are strongly dependent on both the host cell type and the infecting S. aureus strain. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[34] Gordon Y C Cheung,et al. Phenol-soluble modulins--critical determinants of staphylococcal virulence. , 2014, FEMS microbiology reviews.
[35] O. Werz,et al. Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males , 2017, The Journal of clinical investigation.
[36] C. Serhan,et al. Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] W. Seeger,et al. Staphylococcus aureus &agr;-toxin and Escherichia coli hemolysin impair cardiac regional perfusion and contractile function by activating myocardial eicosanoid metabolism in isolated rat hearts , 2009, Critical care medicine.
[38] C. Serhan,et al. Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections , 2015, Nature Medicine.
[39] J. Bubeck Wardenburg,et al. Staphylococcus aureus α-Toxin: Nearly a Century of Intrigue , 2013, Toxins.
[40] Charles N. Serhan,et al. Infection Regulates Pro-Resolving Mediators that Lower Antibiotic Requirements , 2012, Nature.
[41] Eric P. Skaar,et al. Haemin represses the haemolytic activity of Staphylococcus aureus in an Sae-dependent manner. , 2012, Microbiology.
[42] J. Brock,et al. Staphylococcus aureus Fibronectin Binding Proteins Are Essential for Internalization by Osteoblasts but Do Not Account for Differences in Intracellular Levels of Bacteria , 2001, Infection and Immunity.
[43] P. Taylor,et al. 12/15-Lipoxygenase Regulates the Inflammatory Response to Bacterial Products In Vivo1 , 2008, The Journal of Immunology.
[44] Charles N. Serhan,et al. Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.
[45] I. Inoshima,et al. A Staphylococcus aureus Pore-Forming Toxin Subverts the Activity of ADAM10 to Cause Lethal Infection , 2011, Nature Medicine.
[46] Charles N. Serhan,et al. Resolvin E1 and protectin D1 activate inflammation-resolution programmes , 2007, Nature.
[47] T. Schöneberg,et al. Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. , 2010, Cell host & microbe.
[48] R. Proctor,et al. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection , 2011, EMBO molecular medicine.
[49] V. Torres,et al. Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids. , 2014, Trends in microbiology.
[50] Charles N. Serhan,et al. Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.
[51] Yun Zhang,et al. Pore‐forming toxin‐like protein complex expressed by frog promotes tissue repair , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[52] D. Heydeck,et al. Regulation of cellular 15-lipoxygenase activity on pretranslational, translational, and posttranslational levels , 2007, Lipids.
[53] C. Serhan,et al. Novel proresolving and tissue‐regenerative resolvin and protectin sulfido‐conjugated pathways , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[54] W. Seeger,et al. Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal alpha-toxin. , 1997, Journal of immunology.
[55] H. Nakanishi,et al. Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[56] H. Hartung,et al. ADAM‐10 and ADAM‐17 in the inflamed human CNS , 2003, Glia.
[57] W. Seeger,et al. Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: role of thromboxane generation. , 2000, Circulation.
[58] C. Serhan,et al. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. , 2012, Blood.
[59] D. Laouini,et al. Role of Human Macrophage Polarization in Inflammation during Infectious Diseases , 2018, International journal of molecular sciences.
[60] N. Voelkel,et al. Role of eicosanoids in staphylococcal alpha-toxin-induced lung injury in the rat. , 1992, The American journal of physiology.
[61] O. Werz,et al. The novel benzimidazole derivative BRP‐7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5‐lipoxygenase‐activating protein (FLAP) , 2014, British journal of pharmacology.
[62] C. Serhan,et al. Macrophage Proresolving Mediators-the When and Where. , 2016, Microbiology spectrum.
[63] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[64] O. Werz,et al. Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity , 2018, Nature Communications.
[65] N. Hellmann,et al. Staphylococcus aureus α-toxin: small pore, large consequences , 2019, Biological chemistry.
[66] M. Perretti,et al. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis , 2009, Nature.
[67] Àngels González-Lafont,et al. Evolutionary alteration of ALOX15 specificity optimizes the biosynthesis of antiinflammatory and proresolving lipoxins , 2016, Proceedings of the National Academy of Sciences of the United States of America.
[68] C. Leslie,et al. Cytosolic Phospholipase A2 Is Required for Macrophage Arachidonic Acid Release by Agonists That Do and Do Not Mobilize Calcium , 2000, The Journal of Biological Chemistry.
[69] Lei Wu,et al. Fibrinogen-like protein 2 controls sepsis catabasis by interacting with resolvin Dp5 , 2019, Science Advances.
[70] F. Lowy,et al. Staphylococcus aureus infections: transmission within households and the community. , 2015, Trends in microbiology.
[71] O. Werz,et al. Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[72] C. Funk,et al. Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.
[73] M. Otto. Phenol-soluble modulins. , 2014, International journal of medical microbiology : IJMM.